👁️ Diabetic Retinopathy: Why Your Eye Exam Is the Most Important Test You’ll Get

Diabetes is the leading cause of preventable blindness in working‑age adults, and the culprit is almost always diabetic retinopathy. This condition damages the tiny blood vessels in the retina — the light‑sensitive layer at the back of the eye. In its early stages, there are no symptoms. You can see 20/20 and still have retinal damage brewing. That’s why a yearly dilated eye exam is not just a suggestion — it is a non‑negotiable part of your diabetes care. Dr. Ravi Sishir Reddy explains what diabetic retinopathy is, the stages it progresses through, what to expect during an eye exam, and the treatments that can save your vision.

1. How High Blood Sugar Damages Your Eyes

Chronic high blood sugar weakens the walls of the tiny capillaries that nourish the retina. Over time, these capillaries may:

• Leak fluid and blood into the retinal tissue, causing swelling and distorted vision.
• Become blocked, cutting off blood supply to parts of the retina.
• Trigger the growth of abnormal new blood vessels (neovascularisation) that are fragile and prone to bleeding, causing scar tissue and retinal detachment.

These changes progress through specific stages, and the risk increases with the duration of diabetes and the degree of glucose control. High blood pressure and high cholesterol further accelerate the damage.

2. Stages of Diabetic Retinopathy

• Stage 1: Mild Non‑Proliferative Retinopathy (NPDR): Small areas of balloon‑like swelling (microaneurysms) appear in the retinal capillaries. No symptoms. This is the earliest detectable change.
• Stage 2: Moderate NPDR: Some capillaries become blocked, and there may be small haemorrhages and hard exudates (fatty deposits). Vision is still usually normal.
• Stage 3: Severe NPDR: More vessels are blocked, depriving larger areas of the retina of oxygen. The retina signals for new vessel growth. This is a pre‑proliferative stage; the risk of progression to proliferative disease is high.
• Stage 4: Proliferative Diabetic Retinopathy (PDR): Abnormal, fragile new blood vessels grow on the surface of the retina and into the vitreous gel. These can bleed, causing sudden vision loss from vitreous haemorrhage, and can form scar tissue that detaches the retina. This is a vision‑threatening stage requiring immediate treatment.

Another important condition is diabetic macular edema (DME), which is fluid accumulation in the macula — the central part of the retina responsible for sharp, detailed vision. DME can occur at any stage of retinopathy and is the most common cause of vision loss in diabetic eye disease.

3. What Are the Symptoms?

Early stages are completely asymptomatic. As the disease advances, you may notice:

• Blurred or fluctuating vision
• Floaters (dark spots, specks, or cobwebs) drifting in your field of vision
• Dark or empty areas in your central vision
• Difficulty reading or recognising faces
• Sudden, severe loss of vision (if a haemorrhage or retinal detachment occurs)

Dr. Reddy stresses: do not wait for symptoms. Once vision is affected, the damage may be permanent. An annual dilated eye exam can detect retinopathy years before you notice any change.

4. What Happens During a Diabetic Eye Exam?

A comprehensive diabetic eye examination involves:

• Visual acuity test: The standard Snellen chart to measure how well you see at various distances.
• Dilation: Eye drops are placed into each eye to widen (dilate) the pupil. This allows the ophthalmologist or optometrist to see the retina, macula, and optic nerve in detail. The drops may sting briefly and cause blurred vision and light sensitivity for a few hours afterward — bring sunglasses and arrange transport if needed.
• Slit‑lamp examination and indirect ophthalmoscopy: Special lenses provide a magnified, three‑dimensional view of the retina.
• Optical coherence tomography (OCT): A non‑invasive scan that creates high‑resolution cross‑sectional images of the retina, detecting fluid accumulation (macular edema) with micron precision. It’s the best test for diagnosing and monitoring DME.
• Fluorescein angiography: A dye is injected into a vein in your arm and photographed as it circulates through the retinal blood vessels, revealing leaking, blocked, or abnormal vessels. Used selectively when proliferative disease or DME is suspected.

The exam should be performed by an ophthalmologist or an optometrist trained in diabetic eye care. In rural areas, telescreening with a fundus camera can provide initial assessment, but positive findings require referral to a specialist.

5. Recommended Screening Schedule

• Type 2 diabetes: First dilated eye exam at the time of diagnosis, because many people have already had diabetes for years before it is detected. Then, annually if no retinopathy is present.
• Type 1 diabetes: First exam within 5 years of diagnosis, then annually.
• Pregnancy (pre‑existing diabetes): Dilated eye exam before conception or during the first trimester, and then as advised by the ophthalmologist — often every trimester. Women who develop gestational diabetes do not require eye screening unless they have other eye symptoms.
• If any retinopathy is present: Follow‑up intervals shorten to every 6‑9 months for mild NPDR, and every 3‑6 months for moderate to severe NPDR or DME, as determined by the ophthalmologist.

6. How Is Diabetic Retinopathy Treated?

Treatment depends on the stage and whether macular edema is present. The goal is to halt or slow the progression and preserve existing vision.

• Blood sugar, blood pressure, and cholesterol control: The foundation of all treatment. Tight control can reverse early changes and dramatically slow progression to proliferative disease.
• Intravitreal injections (anti‑VEGF therapy): Drugs such as ranibizumab (Lucentis), aflibercept (Eylea), and bevacizumab (Avastin) are injected directly into the eye (after numbing) to block the growth of abnormal vessels and reduce macular edema. This is the first‑line treatment for DME and PDR. Injections are typically given monthly initially, then extended based on response.
• Laser photocoagulation: For proliferative retinopathy, scatter (panretinal) laser burns are applied to the peripheral retina to shrink abnormal vessels and reduce the risk of haemorrhage and retinal detachment. For macular edema, focal laser can seal leaking microaneurysms. Laser is now used less frequently as anti‑VEGF therapy has become the standard, but it remains an important tool.
• Vitrectomy: A surgical procedure to remove blood from the vitreous gel and repair retinal detachment in advanced proliferative disease.

Modern treatment can stabilise vision and often improve it, but it cannot fully restore vision already lost to long‑standing scarring or detachment. Early detection is irreplaceable.

7. Protecting Your Eyes: What You Can Do

• Keep HbA1c below 7% (or your individualised target) — every 1% drop reduces the risk of retinopathy by about 35%.
• Control blood pressure: Aim for <130/80 mmHg. ACE inhibitors and ARBs are particularly beneficial for kidney and eye protection.
• Manage cholesterol: Statins are recommended for most people with diabetes and retinopathy.
• Quit smoking: Tobacco dramatically worsens retinal ischemia.
• Attend your annual eye appointment — even if your vision feels perfect. Treat this as seriously as your HbA1c check.
• Report any vision changes immediately: New floaters, flashes of light, a curtain over your vision, or sudden blurring could indicate a haemorrhage or retinal detachment and need urgent evaluation.